Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease.
Hadinegoro SR, Arredondo-García JL, Capeding MR, Deseda C, Chotpitayasunondh T, Dietze R, Muhammad Ismail HI, Reynales H, Limkittikul K, Rivera-Medina DM, Tran HN, Bouckenooghe A, Chansinghakul D, Cortés M, Fanouillere K, Forrat R, Frago C, Gailhardou S, Jackson N, Noriega F, Plennevaux E, Wartel TA, Zambrano B, Saville M; CYD-TDV Dengue Vaccine Working Group. Hadinegoro SR, et al. N Engl J Med. 2015 Sep 24;373(13):1195-206. doi: 10.1056/NEJMoa1506223. Epub 2015 Jul 27. N Engl J Med. 2015. PMID: 26214039 Free article. Clinical Trial.
Four-year safety follow-up of the tetravalent dengue vaccine efficacy randomized controlled trials in Asia and Latin America.
Arredondo-García JL, Hadinegoro SR, Reynales H, Chua MN, Rivera Medina DM, Chotpitayasunondh T, Tran NH, Deseda CC, Wirawan DN, Cortés Supelano M, Frago C, Langevin E, Coronel D, Laot T, Perroud AP, Sanchez L, Bonaparte M, Limkittikul K, Chansinghakul D, Gailhardou S, Noriega F, Wartel TA, Bouckenooghe A, Zambrano B; CYD-TDV Dengue Vaccine Study Group. Arredondo-García JL, et al. Clin Microbiol Infect. 2018 Jul;24(7):755-763. doi: 10.1016/j.cmi.2018.01.018. Epub 2018 Feb 8. Clin Microbiol Infect. 2018. PMID: 29408333 Free article.
Is discussion of dengue vaccination for the 2016 Olympics necessary?
Arredondo-García JL, Hadinegoro SR, Guy B, Bouckenooghe A, Noriega F, Jackson N. Arredondo-García JL, et al. Lancet. 2016 Oct 15;388(10054):1880-1881. doi: 10.1016/S0140-6736(16)31806-2. Lancet. 2016. PMID: 27751394 No abstract available.
Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
Plennevaux E, Moureau A, Arredondo-García JL, Villar L, Pitisuttithum P, Tran NH, Bonaparte M, Chansinghakul D, Coronel DL, L'Azou M, Ochiai RL, Toh ML, Noriega F, Bouckenooghe A. Plennevaux E, et al. Among authors: arredondo garcia jl. Clin Infect Dis. 2018 Apr 3;66(8):1164-1172. doi: 10.1093/cid/cix966. Clin Infect Dis. 2018. PMID: 29300876 Free PMC article. Clinical Trial.
Efficacy of a tetravalent dengue vaccine in children in Latin America.
Villar L, Dayan GH, Arredondo-García JL, Rivera DM, Cunha R, Deseda C, Reynales H, Costa MS, Morales-Ramírez JO, Carrasquilla G, Rey LC, Dietze R, Luz K, Rivas E, Miranda Montoya MC, Cortés Supelano M, Zambrano B, Langevin E, Boaz M, Tornieporth N, Saville M, Noriega F; CYD15 Study Group. Villar L, et al. N Engl J Med. 2015 Jan 8;372(2):113-23. doi: 10.1056/NEJMoa1411037. Epub 2014 Nov 3. N Engl J Med. 2015. PMID: 25365753 Free article. Clinical Trial.
Controversy and debate on dengue vaccine series-paper 2: response to review of a licensed dengue vaccine: inappropriate subgroup analyses and selective reporting may cause harm in mass vaccination programs.
Hadinegoro SRS, Arredondo-García JL, Capeding MR, Pallardy S, Noriega F, Bouckenooghe A. Hadinegoro SRS, et al. Among authors: arredondo garcia jl. J Clin Epidemiol. 2018 Mar;95:140-141. doi: 10.1016/j.jclinepi.2017.12.024. Epub 2018 Jan 3. J Clin Epidemiol. 2018. PMID: 29306062 No abstract available.
Dengue Vaccine Booster in Healthy Adolescents and Adults in Latin America: Evaluation 4-5 Years After a Primary 3-Dose Schedule.
Coronel D, García-Rivera EJ, Rivera M, Arredondo-García JL, Dietze R, Perroud AP, Cortés M, Bonaparte M, Zhao J, Tila M, Jackson N, Zambrano B, Noriega F. Coronel D, et al. Among authors: arredondo garcia jl. Pediatr Infect Dis J. 2019 May;38(5):e90-e95. doi: 10.1097/INF.0000000000002286. Pediatr Infect Dis J. 2019. PMID: 30986790 Clinical Trial.
Immune Response Persistence and Safety of a Booster Dose of the Tetravalent Dengue Vaccine in Adolescents and Adults Who Previously Completed the 3-dose Schedule 4-5 Years Earlier in Latin America: A Randomized Placebo-controlled Trial.
Coronel D, García-Rivera EJ, Rivera DM, Arredondo-García JL, Dietze R, Perroud AP, Cortés M, Bonaparte M, Wang H, Pagnon A, Jantet-Blaudez F, Peñalosa LAR, Dayan G, Zambrano B, DiazGranados CA, Noriega F. Coronel D, et al. Among authors: arredondo garcia jl. Pediatr Infect Dis J. 2020 Oct;39(10):961-968. doi: 10.1097/INF.0000000000002830. Pediatr Infect Dis J. 2020. PMID: 32932330 Clinical Trial.
99 results